Drug Type Vaccine |
Synonyms Antiallergy vaccine house dust mite Circassia, House dust mite allergy immunotherapy Circassia, ToleroMune HDM |
Target- |
Mechanism Immunomodulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Start Date01 Sep 2014 |
Sponsor / Collaborator Circassia Ltd. [+1] |
Start Date01 Jan 2014 |
Sponsor / Collaborator Circassia Ltd. [+1] |
Start Date01 Jan 2014 |
Sponsor / Collaborator Circassia Ltd. [+1] |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
House dust mite allergy | Phase 2 | US | 01 Sep 2014 | |
House dust mite allergy | Phase 2 | CA | 01 Sep 2014 | |
House dust mite allergy | Phase 2 | FR | 01 Sep 2014 | |
House dust mite allergy | Phase 2 | DE | 01 Sep 2014 | |
House dust mite allergy | Phase 2 | IT | 01 Sep 2014 | |
House dust mite allergy | Phase 2 | NL | 01 Sep 2014 | |
House dust mite allergy | Phase 2 | ZA | 01 Sep 2014 | |
House dust mite allergy | Phase 2 | ES | 01 Sep 2014 | |
Rhinoconjunctivitis | Phase 2 | US | 01 Sep 2014 | |
Rhinoconjunctivitis | Phase 2 | CA | 01 Sep 2014 |
Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
---|
No Data |